| Chagas disease in the United States: a call for increased investment and collaborative research NIA Higuita, NL Beatty, C Forsyth, AF Henao-Martínez, J Manne-Goehler, ... The Lancet Regional Health–Americas 34, 2024 | 11 | 2024 |
| Nutritionally acquired immunodeficiency must be addressed with the same urgency as HIV to end tuberculosis MR Dauphinais, KG Koura, PB Narasimhan, S Mehta, JL Finkelstein, ... BMC Global and Public Health 2 (1), 4, 2024 | 7 | 2024 |
| Not business as usual: Engaging the corporate sector in India’s TB elimination efforts M Carwile, C Cintron, K Jain, G Buonomo, M Oliver, M Dauphinais, ... Global Public Health 18 (1), 2120405, 2023 | 3 | 2023 |
| Intestinal Parasitic Infections May Be Overlooked Drivers of the Tuberculosis Pandemic. LB Steel, PB Narasimhan, M Chaudhari, MR Dauphinais, S Huang, ... The American journal of tropical medicine and hygiene 111 (4), 719-723, 2024 | 1 | 2024 |
| Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection—a Multicenter Prospective Cohort Analysis P Sinha, K Ezhumalai, X Du, C Ponnuraja, MR Dauphinais, N Gupte, ... Clinical Infectious Diseases, ciae149, 2024 | 1 | 2024 |
| The ABCDs of nutritional assessment in infectious diseases research LM Locks, A Parekh, K Newell, MR Dauphinais, C Cintron, K Maloomian, ... The Journal of Infectious Diseases, jiae540, 2024 | | 2024 |
| Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India S Prakash Babu, K Ezhumalai, K Raghupathy, M Karoly, P Chinnakali, ... Clinical Infectious Diseases 79 (4), 1034-1038, 2024 | | 2024 |
| Clearing the air: microcosting the carbon impact of drug-susceptible pulmonary TB treatment MF Martins, MR Dauphinais, A Tabackman, PB Narasimhan, MC Nielsen, ... The international journal of tuberculosis and lung disease: the official …, 2024 | | 2024 |
| In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a … P Sinha, M Dauphinais, ME Carwile, CR Horsburgh, NA Menzies medRxiv, 2024 | | 2024 |
| National Institutes of Health Funding for Tuberculosis Comorbidities Is Disproportionate to Their Epidemiologic Impact M Carwile, SJ Pan, V Zhang, M Dauphinais, C Cintron, D Flynn, AM Tang, ... Open Forum Infectious Diseases 11 (1), ofad618, 2024 | | 2024 |
| A micro-costing analysis of nutritional support for persons with TB and their families in India G Buonomo, C Acuña-Villaorduna, V Poongothai, M Dharmalingam, ... Public Health Action 13 (2), 34-36, 2023 | | 2023 |
| A Microcosting Analysis of Nutritional Support for Persons Living With Tuberculosis and Their Families in India G Buonomo, C Acuña-Villaorduna, V Poongothai, M Dharmalingam, ... A61. TUBERCULOSIS, A2067-A2067, 2023 | | 2023 |
| A Systematic Review of National Institutes of Health Funding for Tuberculosis Comorbidities M Carwile, V Zhang, M Dauphinais, C Cintron, D Flynn, A Tang, P Sinha A27. WHITE PLAGUE (TUBERCULOSIS) RESEARCH, A1216-A1216, 2023 | | 2023 |
